Orthofix International | OFIX - Los Gastos De Explotación

Precio De Mercado
12.38
Cambio Diario
-0.04 -0.32%
Mensual
0.90%
Anual
-9.44%
Q2 Expectativa
12.04




Los Gastos De Explotación Cambio Fecha
Accuray USD 37.18M 567K 2024-12
AngioDynamics USD 81.95M 1.68M 2025-09
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 138.01M 3.95M 2025-12
Dexcom USD 936.6M 30.2M 2025-12
EDAP TMS EUR 18.8M 3.01M 2025-09
Globus Medical USD 645.11M 241.46M 2025-12
Hologic USD 349.4M 447.1M 2025-12
Inogen USD 49.14M 665K 2024-09
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
J&J USD 18.97B 2.38B 2025-12
Medtronic USD 7.28B 16M 2025-12
Mesa Laboratories USD 33.98M 2.03M 2024-12
Orthofix International USD 213.79M 12.36M 2025-12
Plus Therapeutics USD 7.11M 1.23M 2025-12
Smith & Nephew USD 2.52B 84M 2025-12
STAAR Surgical USD 68.74M 1.55M 2025-12
Stryker USD 5.2B 505M 2025-12
Surmodics USD 29.51M 274.86M 2025-06
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
Veracyte USD 116M 7.24M 2025-12
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12